Lee Min Hee, Sharma Amit, Chang Min Jung, Lee Jinju, Son Subin, Sessler Jonathan L, Kang Chulhun, Kim Jong Seung
Department of Chemistry, Sookmyung Women's University, Seoul 04310, Korea.
Chem Soc Rev. 2018 Jan 2;47(1):28-52. doi: 10.1039/c7cs00557a.
Theranostic systems are receiving ever-increasing attention due to their potential therapeutic utility, imaging enhancement capability, and promise for advancing the field of personalized medicine, particularly as it relates to the diagnosis, staging, and treatment of cancer. In this Tutorial Review, we provide an introduction to the concepts of theranostic drug delivery effected via use of conjugates that are able to target cancer cells selectively, provide cytotoxic chemotherapeutics, and produce readily monitored imaging signals in vitro and in vivo. The underlying design concepts, requiring the synthesis of conjugates composed of imaging reporters, masked chemotherapeutic drugs, cleavable linkers, and cancer targeting ligands, are discussed. Particular emphasis is placed on highlighting the potential benefits of fluorogenic reaction-based targeted systems that are activated for both imaging and therapy by cellular entities, e.g., thiols, reactive oxygen species and enzymes, which are present at relatively elevated levels in tumour environments, physiological characteristics of cancer, e.g., hypoxia and acidic pH. Also discussed are systems activated by an external stimulus, such as light. The work summarized in this Tutorial Review will help define the role fluorogenic reaction-based, cancer-targeting theranostics may have in advancing drug discovery efforts, as well as improving our understanding of cellular uptake and drug release mechanisms.
由于其潜在的治疗效用、成像增强能力以及在推进个性化医疗领域（特别是与癌症的诊断、分期和治疗相关）的前景，治疗诊断系统正受到越来越多的关注。在本教程综述中，我们介绍了通过使用能够选择性靶向癌细胞、提供细胞毒性化疗药物并在体外和体内产生易于监测的成像信号的缀合物来实现治疗诊断药物递送的概念。讨论了其潜在的设计理念，这需要合成由成像报告分子、掩蔽化疗药物、可裂解连接子和癌症靶向配体组成的缀合物。特别强调突出基于荧光反应的靶向系统的潜在益处，这些系统可被细胞实体（如硫醇、活性氧和酶）激活用于成像和治疗，这些细胞实体在肿瘤环境中相对较高水平存在，同时也强调癌症的生理特征（如缺氧和酸性pH）。还讨论了由外部刺激（如光）激活的系统。本教程综述中总结的工作将有助于确定基于荧光反应的癌症靶向治疗诊断在推进药物发现工作以及增进我们对细胞摄取和药物释放机制理解方面可能发挥的作用。
